Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Adenocarcinoma|Invasive Breast Carcinoma|Triple-Negative Breast Carcinoma
Interventions: DRUG: Atezolizumab|DRUG: Nab-paclitaxel
Sponsor: M.D. Anderson Cancer Center